Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Vicore Pharma Holding AB(VCRE) the Revenue is 228.06 K (+23.94%), Beat estimate;the EBIT is -15.47 M (-32.03%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B23.94%
0.00B69.98%
+0.00B93.92%
EBITMiss expectations
-0.02B32.03%
-0.01B16.60%
-0.00B15.43%
EPS
TBA--
-0.0423--
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 5, 2026
Estimate Revenue59.35 K
Estimate EBIT--
Estimate EPS-0.0434
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf